Magnetic gel takes aim at oral cancer risk
NCT ID NCT06271564
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a gel containing magnetite zinc oxide nanoparticles on 24 people with oral precancerous lesions. The gel was applied three times daily for six weeks. Researchers measured changes in lesion size and tissue health. This is an early trial to see if the gel is safe and might work.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Magnetite zinc oxide composite nanoparticle gel
- What this could lead to
- If it works, this could offer a simple gel treatment for oral precancerous lesions, potentially avoiding surgery.
- What could go wrong
- This is a very early, small trial with only 24 people. The gel has only been tested in lab dishes before, so it may not work in humans or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL POTENTIALLY MALIGNANT LESIONS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Dentistry Ain shams University
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.